Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| NORTHROP GRUMMAN CORP /DE/NOC · Entity 2963 | CVP & Chief Financial Officer | February 18, 2025 | February 20, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
NORTHROP GRUMMAN CORP /DE/
Report date February 18, 2025 · Filed February 20, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 2,644.68 |
Ending reported balance
After 2025-02-18 transaction · row 4
4 source rows · reconciled sequenceRow 1 · 2025-02-18 · Exercise / conversion · Acquired 593.85 · Balance 2,659.68 Row 2 · 2025-02-18 · Tax withholding · Disposed 184 · Balance 2,475.68 Row 3 · 2025-02-18 · Exercise / conversion · Acquired 253 · Balance 2,728.68 Row 4 · 2025-02-18 · Tax withholding · Disposed 84 · Balance 2,644.68 |
| Restricted Performance Stock RightsSEC Table II · derivative / convertible security | Direct | 9,151.85 |
Reported balance
After 2025-02-18 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2025-02-18 · Grant · Acquired 4,628.85 · Balance 9,151.85 F2: Each Restricted Performance Stock Right ("RPSR") represents a contingent right to receive an equivalent number of shares of Issuer common stock, or, at the Issuer's election, cash or a combination of cash and Issuer common stock. The RPSRs vest if the applicable performance metric is satisfied for the relevant measurement period. Grants awarded pursuant to Rule 16b-3(d). F3: The RPSRs acquired include (i) 38.85 vested RPSRs with respect to the measurement period ended 12/31/24 acquired due to settlement of the RPSRs granted under the 2011 Long-Term Incentive Stock Plan ("2011 LTISP") on 2/15/22 that resulted in settlement at 107% of the target award; and (ii) 4,590 unvested RPSRs granted under the 2024 Long-Term Incentive Stock Plan (the "2024 LTISP") on 2/18/25 with a measurement period ending on 12/31/27. A total of 593.85 shares were issued in settlement of the 2022 RPSRs with a measurement period that ended 12/31/24, and the target award amount of 555 RPSRs was previously reported in connection with the grant of the 2022 RPSRs. F4: Total amount includes (i) 593.85 vested RPSRs granted under the 2011 LTISP on 2/15/22 with a measurement period ended on 12/31/24; (ii) 542 RPSRs granted under the 2011 LTISP on 2/16/23 with a measurement period ending on 12/31/25; (iii) 627 RPSRs granted under the 2011 LTISP on 2/14/24 with a measurement period ending on 12/31/26; (iv) 2,799 RPSRs granted under the 2024 LTISP on 7/31/24 with a measurement period ending 12/31/26; and (v) 4,590 RPSRs granted under the 2024 LTISP on 2/18/25 with a measurement period ending on 12/31/27. |
| Restricted Performance Stock RightsSEC Table II · derivative / convertible security | Direct | 8,558 |
Reported balance
After 2025-02-18 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2025-02-18 · Exercise / conversion · Disposed 593.85 · Balance 8,558 F2: Each Restricted Performance Stock Right ("RPSR") represents a contingent right to receive an equivalent number of shares of Issuer common stock, or, at the Issuer's election, cash or a combination of cash and Issuer common stock. The RPSRs vest if the applicable performance metric is satisfied for the relevant measurement period. Grants awarded pursuant to Rule 16b-3(d). F8: Total amount includes (i) 542 RPSRs granted under the 2011 LTISP on 2/16/23 with a measurement period ending on 12/31/25; (ii) 627 RPSRs granted under the 2011 LTISP on 2/14/24 with a measurement period ending on 12/31/26; (iii) 2,799 RPSRs granted under the 2024 LTISP on 7/31/24 with a measurement period ending 12/31/26; and (iv) 4,590 RPSRs granted under the 2024 LTISP on 2/18/25 with a measurement period ending on 12/31/27. |
| Restricted Stock RightsSEC Table II · derivative / convertible security | Direct | 4,136 |
Reported balance
After 2025-02-18 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2025-02-18 · Grant · Acquired 2,105 · Balance 4,136 F5: Each Restricted Stock Right ("RSR") represents a contingent right to receive an equivalent number of shares in Issuer common stock, or, at the election of the Issuer's Compensation Committee, cash or a combination of cash and Issuer common stock. F6: The RSRs were granted under the 2024 LTISP on 2/18/2025 and will vest on 2/18/2028. F7: Total amount includes (i) 253 RSRs granted under the 2011 LTISP on 2/15/22 that vested on 2/18/25; (ii) 232 RSRs granted under the 2011 LTISP on 2/16/23 that will vest on 2/17/26; (iii) 269 RSRs granted under the 2011 LTISP on 2/14/24 that will vest on 2/16/27; (iv) 1,277 RSRs granted under the 2024 LTISP on 7/31/24 that will vest on 8/2/2027; and (v) 2,105 RSRs granted under 2024 LTISP on 2/18/25 that will vest on 2/18/28. |
| Restricted Stock RightsSEC Table II · derivative / convertible security | Direct | 3,883 |
Reported balance
After 2025-02-18 transaction · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · 2025-02-18 · Exercise / conversion · Disposed 253 · Balance 3,883 F5: Each Restricted Stock Right ("RSR") represents a contingent right to receive an equivalent number of shares in Issuer common stock, or, at the election of the Issuer's Compensation Committee, cash or a combination of cash and Issuer common stock. F9: Shares issued upon vesting of RSRs granted under the 2011 LTISP on 2/15/22 that vested on 2/18/25. |
| Common StockSEC Table I · non-derivative | IndirectHeld in the Northrop Grumman Savings Excess Plan | 84.4492 |
Reported balance
Holding disclosure · report date 2025-02-18 · row 5
Holding and transaction disclosures are not merged.
1 source rowRow 5 · Balance 84.4492 F1: Held in the Northrop Grumman Savings Excess Plan (the "Plan"), as of February 18, 2025. Share totals with respect to the Plan are based upon unit accounting and therefore may reflect a change in units attributable to an individual though no acquisition or disposition occurred. |
Filing footnotes · ownership attribution and instrument terms
F1: Held in the Northrop Grumman Savings Excess Plan (the "Plan"), as of February 18, 2025. Share totals with respect to the Plan are based upon unit accounting and therefore may reflect a change in units attributable to an individual though no acquisition or disposition occurred.
F2: Each Restricted Performance Stock Right ("RPSR") represents a contingent right to receive an equivalent number of shares of Issuer common stock, or, at the Issuer's election, cash or a combination of cash and Issuer common stock. The RPSRs vest if the applicable performance metric is satisfied for the relevant measurement period. Grants awarded pursuant to Rule 16b-3(d).
F3: The RPSRs acquired include (i) 38.85 vested RPSRs with respect to the measurement period ended 12/31/24 acquired due to settlement of the RPSRs granted under the 2011 Long-Term Incentive Stock Plan ("2011 LTISP") on 2/15/22 that resulted in settlement at 107% of the target award; and (ii) 4,590 unvested RPSRs granted under the 2024 Long-Term Incentive Stock Plan (the "2024 LTISP") on 2/18/25 with a measurement period ending on 12/31/27. A total of 593.85 shares were issued in settlement of the 2022 RPSRs with a measurement period that ended 12/31/24, and the target award amount of 555 RPSRs was previously reported in connection with the grant of the 2022 RPSRs.
F4: Total amount includes (i) 593.85 vested RPSRs granted under the 2011 LTISP on 2/15/22 with a measurement period ended on 12/31/24; (ii) 542 RPSRs granted under the 2011 LTISP on 2/16/23 with a measurement period ending on 12/31/25; (iii) 627 RPSRs granted under the 2011 LTISP on 2/14/24 with a measurement period ending on 12/31/26; (iv) 2,799 RPSRs granted under the 2024 LTISP on 7/31/24 with a measurement period ending 12/31/26; and (v) 4,590 RPSRs granted under the 2024 LTISP on 2/18/25 with a measurement period ending on 12/31/27.
F5: Each Restricted Stock Right ("RSR") represents a contingent right to receive an equivalent number of shares in Issuer common stock, or, at the election of the Issuer's Compensation Committee, cash or a combination of cash and Issuer common stock.
F6: The RSRs were granted under the 2024 LTISP on 2/18/2025 and will vest on 2/18/2028.
F7: Total amount includes (i) 253 RSRs granted under the 2011 LTISP on 2/15/22 that vested on 2/18/25; (ii) 232 RSRs granted under the 2011 LTISP on 2/16/23 that will vest on 2/17/26; (iii) 269 RSRs granted under the 2011 LTISP on 2/14/24 that will vest on 2/16/27; (iv) 1,277 RSRs granted under the 2024 LTISP on 7/31/24 that will vest on 8/2/2027; and (v) 2,105 RSRs granted under 2024 LTISP on 2/18/25 that will vest on 2/18/28.
F8: Total amount includes (i) 542 RPSRs granted under the 2011 LTISP on 2/16/23 with a measurement period ending on 12/31/25; (ii) 627 RPSRs granted under the 2011 LTISP on 2/14/24 with a measurement period ending on 12/31/26; (iii) 2,799 RPSRs granted under the 2024 LTISP on 7/31/24 with a measurement period ending 12/31/26; and (iv) 4,590 RPSRs granted under the 2024 LTISP on 2/18/25 with a measurement period ending on 12/31/27.
F9: Shares issued upon vesting of RSRs granted under the 2011 LTISP on 2/15/22 that vested on 2/18/25.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 18, 2025 Filed Feb 20, 2025 22:13 UTC | NORTHROP GRUMMAN CORP /DE/ NOC · Entity 2963 | Exercise / conversionRestricted Stock Rights · Derivative | 253 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-006853 · wk-form4_1740089599.xml · derivative · entry 9 Crews Kenneth B. · CIK 0002026642 · CVP & Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,883 Underlying: Common Stock · 253 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: Each Restricted Stock Right ("RSR") represents a contingent right to receive an equivalent number of shares in Issuer common stock, or, at the election of the Issuer's Compensation Committee, cash or a combination of cash and Issuer common stock. F5 · derivative.exercise_date: Each Restricted Stock Right ("RSR") represents a contingent right to receive an equivalent number of shares in Issuer common stock, or, at the election of the Issuer's Compensation Committee, cash or a combination of cash and Issuer common stock. F9 · derivative.expiration_date: Shares issued upon vesting of RSRs granted under the 2011 LTISP on 2/15/22 that vested on 2/18/25. Read SEC document |
| February 18, 2025 Filed Feb 20, 2025 22:13 UTC | NORTHROP GRUMMAN CORP /DE/ NOC · Entity 2963 | Exercise / conversionRestricted Performance Stock Rights · Derivative | 593.85 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-006853 · wk-form4_1740089599.xml · derivative · entry 8 Crews Kenneth B. · CIK 0002026642 · CVP & Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,558 Underlying: Common Stock · 593.85 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each Restricted Performance Stock Right ("RPSR") represents a contingent right to receive an equivalent number of shares of Issuer common stock, or, at the Issuer's election, cash or a combination of cash and Issuer common stock. The RPSRs vest if the applicable performance metric is satisfied for the relevant measurement period. Grants awarded pursuant to Rule 16b-3(d). F2 · derivative.exercise_date: Each Restricted Performance Stock Right ("RPSR") represents a contingent right to receive an equivalent number of shares of Issuer common stock, or, at the Issuer's election, cash or a combination of cash and Issuer common stock. The RPSRs vest if the applicable performance metric is satisfied for the relevant measurement period. Grants awarded pursuant to Rule 16b-3(d). F2 · derivative.expiration_date: Each Restricted Performance Stock Right ("RPSR") represents a contingent right to receive an equivalent number of shares of Issuer common stock, or, at the Issuer's election, cash or a combination of cash and Issuer common stock. The RPSRs vest if the applicable performance metric is satisfied for the relevant measurement period. Grants awarded pursuant to Rule 16b-3(d). F8 · balance_after: Total amount includes (i) 542 RPSRs granted under the 2011 LTISP on 2/16/23 with a measurement period ending on 12/31/25; (ii) 627 RPSRs granted under the 2011 LTISP on 2/14/24 with a measurement period ending on 12/31/26; (iii) 2,799 RPSRs granted under the 2024 LTISP on 7/31/24 with a measurement period ending 12/31/26; and (iv) 4,590 RPSRs granted under the 2024 LTISP on 2/18/25 with a measurement period ending on 12/31/27. Read SEC document |
| February 18, 2025 Filed Feb 20, 2025 22:13 UTC | NORTHROP GRUMMAN CORP /DE/ NOC · Entity 2963 | GrantRestricted Stock Rights · Derivative | 2,105 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-006853 · wk-form4_1740089599.xml · derivative · entry 7 Crews Kenneth B. · CIK 0002026642 · CVP & Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,136 Underlying: Common Stock · 2,105 shares Expires not disclosed F5 · derivative.exercise_price: Each Restricted Stock Right ("RSR") represents a contingent right to receive an equivalent number of shares in Issuer common stock, or, at the election of the Issuer's Compensation Committee, cash or a combination of cash and Issuer common stock. F5 · derivative.exercise_date: Each Restricted Stock Right ("RSR") represents a contingent right to receive an equivalent number of shares in Issuer common stock, or, at the election of the Issuer's Compensation Committee, cash or a combination of cash and Issuer common stock. F6 · derivative.expiration_date: The RSRs were granted under the 2024 LTISP on 2/18/2025 and will vest on 2/18/2028. F7 · balance_after: Total amount includes (i) 253 RSRs granted under the 2011 LTISP on 2/15/22 that vested on 2/18/25; (ii) 232 RSRs granted under the 2011 LTISP on 2/16/23 that will vest on 2/17/26; (iii) 269 RSRs granted under the 2011 LTISP on 2/14/24 that will vest on 2/16/27; (iv) 1,277 RSRs granted under the 2024 LTISP on 7/31/24 that will vest on 8/2/2027; and (v) 2,105 RSRs granted under 2024 LTISP on 2/18/25 that will vest on 2/18/28. Read SEC document |
| February 18, 2025 Filed Feb 20, 2025 22:13 UTC | NORTHROP GRUMMAN CORP /DE/ NOC · Entity 2963 | GrantRestricted Performance Stock Rights · Derivative | 4,628.85 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-006853 · wk-form4_1740089599.xml · derivative · entry 6 Crews Kenneth B. · CIK 0002026642 · CVP & Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,151.85 Underlying: Common Stock · 4,628.85 shares Expires not disclosed F2 · derivative.exercise_price: Each Restricted Performance Stock Right ("RPSR") represents a contingent right to receive an equivalent number of shares of Issuer common stock, or, at the Issuer's election, cash or a combination of cash and Issuer common stock. The RPSRs vest if the applicable performance metric is satisfied for the relevant measurement period. Grants awarded pursuant to Rule 16b-3(d). F3 · shares: The RPSRs acquired include (i) 38.85 vested RPSRs with respect to the measurement period ended 12/31/24 acquired due to settlement of the RPSRs granted under the 2011 Long-Term Incentive Stock Plan ("2011 LTISP") on 2/15/22 that resulted in settlement at 107% of the target award; and (ii) 4,590 unvested RPSRs granted under the 2024 Long-Term Incentive Stock Plan (the "2024 LTISP") on 2/18/25 with a measurement period ending on 12/31/27. A total of 593.85 shares were issued in settlement of the 2022 RPSRs with a measurement period that ended 12/31/24, and the target award amount of 555 RPSRs was previously reported in connection with the grant of the 2022 RPSRs. F2 · derivative.exercise_date: Each Restricted Performance Stock Right ("RPSR") represents a contingent right to receive an equivalent number of shares of Issuer common stock, or, at the Issuer's election, cash or a combination of cash and Issuer common stock. The RPSRs vest if the applicable performance metric is satisfied for the relevant measurement period. Grants awarded pursuant to Rule 16b-3(d). F2 · derivative.expiration_date: Each Restricted Performance Stock Right ("RPSR") represents a contingent right to receive an equivalent number of shares of Issuer common stock, or, at the Issuer's election, cash or a combination of cash and Issuer common stock. The RPSRs vest if the applicable performance metric is satisfied for the relevant measurement period. Grants awarded pursuant to Rule 16b-3(d). F4 · balance_after: Total amount includes (i) 593.85 vested RPSRs granted under the 2011 LTISP on 2/15/22 with a measurement period ended on 12/31/24; (ii) 542 RPSRs granted under the 2011 LTISP on 2/16/23 with a measurement period ending on 12/31/25; (iii) 627 RPSRs granted under the 2011 LTISP on 2/14/24 with a measurement period ending on 12/31/26; (iv) 2,799 RPSRs granted under the 2024 LTISP on 7/31/24 with a measurement period ending 12/31/26; and (v) 4,590 RPSRs granted under the 2024 LTISP on 2/18/25 with a measurement period ending on 12/31/27. Read SEC document |
| February 18, 2025 Filed Feb 20, 2025 22:13 UTC | NORTHROP GRUMMAN CORP /DE/ NOC · Entity 2963 | Tax withholdingCommon Stock | 84 | $441.36 | $37,074.24 |
DisclosureSEC source: 0001628280-25-006853 · wk-form4_1740089599.xml · nonDerivative · entry 4 Crews Kenneth B. · CIK 0002026642 · CVP & Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,644.68 Read SEC document |
| February 18, 2025 Filed Feb 20, 2025 22:13 UTC | NORTHROP GRUMMAN CORP /DE/ NOC · Entity 2963 | Exercise / conversionCommon Stock | 253 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-006853 · wk-form4_1740089599.xml · nonDerivative · entry 3 Crews Kenneth B. · CIK 0002026642 · CVP & Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,728.68 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 18, 2025 Filed Feb 20, 2025 22:13 UTC | NORTHROP GRUMMAN CORP /DE/ NOC · Entity 2963 | Tax withholdingCommon Stock | 184 | $441.36 | $81,210.24 |
DisclosureSEC source: 0001628280-25-006853 · wk-form4_1740089599.xml · nonDerivative · entry 2 Crews Kenneth B. · CIK 0002026642 · CVP & Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,475.68 Read SEC document |
| February 18, 2025 Filed Feb 20, 2025 22:13 UTC | NORTHROP GRUMMAN CORP /DE/ NOC · Entity 2963 | Exercise / conversionCommon Stock | 593.85 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-006853 · wk-form4_1740089599.xml · nonDerivative · entry 1 Crews Kenneth B. · CIK 0002026642 · CVP & Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,659.68 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.